+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 40Years - 74Years
All Genders
Healthy Volunteers
ID06741293

Study to Find Gut Microbiome Markers in Stool for Early Detection and Screening of Colorectal Cancer in Adults Aged 40 to 74 in Lisbon, Portugal

Led by Gulbenkian Institute for Molecular Medicine · Updated on 2026-05-14

30000

Participants Needed

1

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Colorectal cancer CRC is a major health challenge worldwide, with increasing incidence and mortality, especially in people under 50 years old. In Portugal, CRC is the most common cancer and the second leading cause of cancer-related deaths. Early detection is vital since survival rates drop significantly as the disease advances. This study aims to identify gut microbiome markers in stool samples to improve early detection of CRC and high-risk adenomas, as changes in gut bacteria may indicate susceptibility to cancer. The study will observe individuals aged 40 to 74 years living in the Lisbon Metropolitan Area. Stool samples will be collected and analyzed using advanced techniques to find microbiome biomarkers linked to CRC and precancerous lesions. Participants will provide samples at the start and then every two years over six years. Researchers will also gather information on participants health, lifestyle, and diet to explore connections with CRC risk and microbiome profiles. Participants will complete questionnaires and telephone interviews about their clinical history, lifestyle, physical activity, diet, stress, and body measurements. Stool samples will be collected within 2 to 10 days after enrollment and every two years thereafter. The study will measure microbiome biomarkers and compare them with results from standard tests like the Faecal Immunochemical Test FIT and colonoscopy. This long-term monitoring aims to develop a more sensitive, non-invasive screening tool and better understand risk factors for CRC.

CONDITIONS

Brief Title

Improving Colorectal Cancer Early Screening in Portugal: Identification of Gut Microbiome Biomarkers in Stool (GUTBIOME-PT)

Research Team

A

Ana S Almeida, PhD

M

Madalena Reis

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here